In the second quarter of fiscal 2026, Elite Pharmaceuticals posted revenues of $36.3 million, up 92.4% year over year from $18.9 million, driven largely by the launch and rapid expansion of its ...

Total Revenue: $18.8 million for the quarter, a 109% increase from $8.9 million in the prior year quarter. Operating Income: $3.9 million, up from $1.6 million in the previous year, marking a 141% ...

Shares of Elite Pharmaceuticals, Inc. ELTP have lost 3.3% since the company reported its earnings for the quarter ended Dec. 31, 2024. This compares to the S&P 500 Index’s 1.2% gain over the same time ...

Elite Pharmaceuticals Inc. Annual cash flow by MarketWatch. View ELTP net cash flow, operating cash flow, operating expenses and cash dividends.

Two biotech companies had a rough end to the week last week, and it looks as though things aren’t going to get much better for them heading into the US open on Monday. Here’s what happened. Of the two ...

Access detailed historical stock prices, including daily closing prices, for ELTP. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...